Jennifer Lynn Minai Azary is Chief Financial Officer of Context Therapeutics Inc.. Currently has a direct ownership of 40,000 shares of CNTX, which is worth approximately $40,800. The most recent transaction as insider was on Dec 16, 2022, when has been sold 25,000 shares (Common Stock) at a price of $0.74 per share, resulting in proceeds of $18,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K
0% 3M change
0% 12M change
Total Value Held $40,800

Jennifer Lynn Minai-Azary Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2022
BUY
Open market or private purchase
$18,500 $0.74 p/Share
25,000 Added 38.46%
40,000 Common Stock
Aug 17 2022
BUY
Open market or private purchase
$27,000 $1.8 p/Share
15,000 Added 50.0%
15,000 Common Stock

Also insider at

TPST
Tempest Therapeutics, Inc. Healthcare
JLM

Jennifer Lynn Minai Azary

Chief Financial Officer
Philadelphia, PA

Track Institutional and Insider Activities on CNTX

Follow Context Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTX shares.

Notify only if

Insider Trading

Get notified when an Context Therapeutics Inc. insider buys or sells CNTX shares.

Notify only if

News

Receive news related to Context Therapeutics Inc.

Track Activities on CNTX